Journal profile · ONCOLOGY
Journal of Kidney Cancer and VHL
ISSN 2203-5826 · Codon Publications · Australia
Journal of Kidney Cancer and VHL: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.3 (journal website); diamond open access (no APC); no APC; median 101 days to acceptance (47 articles, last 24 months); 27 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Journal of Kidney Cancer and VHL is published by Codon Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Renal cell carcinoma treatment, Renal and related cancers and Cancer Genomics and Diagnostics, together about 56.6% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Revised Title Name from January 1, 2025 From January 1, 2025 the Journal of Kidney Cancer and VHL will publish with its revised title name of Journal of Kidney Cancer with same ISSN No 2203-5826. Journal of Kidney Cancer (ISSN: 2203-5826) is a peer-reviewed, online-only, open access journal dedicated for the dissemination of research findings in kidney cancer and VHL. Kidney cancer, also known as renal cell carcinoma, is relatively rare representing approximately 2% of all cancers. Aberrations in the von Hippel-Lindau gene (VHL) are the major risk factors for the development of kidney cancer. VHL aberrations, by themselves, also cause another rare condition called VHL syndrome. The incidence of VHL syndrome is estimated to be 1 in 36,000 individuals. Journal of Kidney Cancer aims to be a scholarly forum for the exchange of knowledge which will enable scientists to develop better treatment strategies for the management of these two disorders. The journal will publish basic science and clinical research articles on all aspects of kidney cancer and VHL. Original articles, comprehensive reviews, case reports, short communications, and letter to the editor are suitable for submission. Scope Key Words: Renal Cell Carcinoma; Renal Angiomyolipoma; Small Renal Masses; Wilms Tumor/Nephroblastoma; WT1. Cystadenomas, Endolymphatic Sac Tumors; Hemangioma; Hemangioblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; VHL Syndrome.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Ulka VaishampayanPublisher website
Editorial board by country: none in mainland China; most named United States 6, Malaysia 5, Türkiye 3, India 2, Denmark 2 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Renal cell carcinoma treatmentMedicine30.5%
- Renal and related cancersBiochemistry, Genetics and Molecular Biology18.8%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology7.4%
- Bladder and Urothelial Cancer TreatmentsMedicine6.5%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology6.5%
- Adrenal and Paraganglionic TumorsMedicine3.3%
- Tuberous Sclerosis Complex ResearchMedicine2.9%
- Cancer Diagnosis and TreatmentMedicine2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.3Publisher website ·
- h-index
- 25OpenAlex ·
- i10-index
- 64OpenAlex ·
- 2-year mean citedness
- 1.51OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 68.42%LetPub ·
Volume
- Articles per year
- 24LetPub ·
Articles by year OpenAlex count · 236 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 13 | 13 | 1 |
| 2025 | 27 | 27 | 38 |
| 2024 | 30 | 30 | 67 |
| 2023 | 24 | 24 | 123 |
| 2022 | 22 | 22 | 170 |
| 2021 | 27 | 27 | 187 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
101 daysMedian, submission to acceptance · P25–P75 74 days – 167 days
- Acceptance to online
- median 26 days (47 articles)
- Submission to online
- median 131 days
- Sample
- 47 articles with submission and acceptance dates (49 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 4 weeksLetPub ·
- Submission to publication (journal-reported)
- about 4 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 5
- Reference style
- Vancouver
- Suggested reviewers
- Optional
Article types accepted3
- case reportsManuscript Preparation Guidelines for Case ReportsLength not stated
- original articlesManuscript Preparation Guidelines for Original ArticlesLength not stated
- review articlesManuscript Preparation Guidelines for Review ArticlesLength not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, Peer review
- Authorship
Manuscript guidelines based on ICMJE recommendations. Model summary
These guidelines are based on ICMJE recommendations.
Source ↗Publisher website ·- Conflicts of interest
Conflict of interest declaration is mandatory. Model summary
Conflict of interest: This is mandatory. Declare any conflicts of interest that are pertinent to the current manuscript.
Source ↗Publisher website ·- Publication ethics
Ethics approval statement and number required when relevant. Model summary
If relevant, include a statement about ethics approval and ethics approval number.
Source ↗Publisher website ·- Peer review
Language editing may be required; articles needing language editing are returned without peer review. Model summary
All submitted manuscripts will be assessed for language by the editorial office, and articles that require language editing will be returned to the authors without peer review.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Codon Publications
- Country or region
- Australia
- Language
- English
- ISSN
- 2203-5826
- Latest issue on the website
- Volume 13, Issue 3 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Kidney Cancer and VHL
What CAS zone is Journal of Kidney Cancer and VHL in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Kidney Cancer and VHL is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Kidney Cancer and VHL?
The journal's website gives an impact factor of 1.3 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 25.
How long does peer review take at Journal of Kidney Cancer and VHL?
Based on the dates recorded on 47 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 101 days (interquartile range 74–167 days); authors report an average review time of about 4 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Kidney Cancer and VHL?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 5; Reference style: Vancouver; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Kidney Cancer and VHL based?
Of the 22 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (6), Malaysia (5) and Türkiye (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Kidney Cancer and VHL?
According to LetPub and DOAJ records, Journal of Kidney Cancer and VHL is indexed in ESCI and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is Journal of Kidney Cancer and VHL open access, and what is the APC?
Journal of Kidney Cancer and VHL is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .